Buy the Dip and Stack the Deck with Biotech

Hey Trader, You might have noticed that I've been talking about biotech a lot lately. That's no mistake. It's a blend of two of the hottest sectors in the market. And here we go again, with another biotech making moves. Recently, we saw the CEO and several directors gobble up over $330k in stocks. Wonder why? Do you think they know something that we don't? Click here to see how we stalk insider trades to big profits! This company is making significant advances in the area of cancer research. They had a big win with a patent approval a few months ago that put some wind in their sails and contributed to a strong rally. But then the bad news hit, and they took a dip. One of their products got tangled up in a little FDA red tape, which caused a delay in the process. Move along. Nothing to see here, but a little bureaucracy at work. True to form, the insiders tipped their hand for us again and bought into the less than desirable results. Now that we know what the smart money is doing, we'll follow suit and profit when they do. Click here to discover our powerful strategy! Do it soon, because this window of opportunity won't last forever! See you on the inside, Dustin Pass Editor, Insider Report Market Traders Daily Director of Client Services 888-228-2376 Disclaimer:Futures, forex, stock, and options trading are not appropriate for all traders. There is a substantial risk of loss associated with trading these markets. Losses can and will occur. No system or methodology has ever been developed that can ensure returns or against losses. No representation or implication is being made that using any of these methodologies or systems will generate returns or ensure against losses.

If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
Global Profit Systems International, 15502 Stoneybrook West Parkway Suite 104-153, Winter Garden, FL 34787, US